Rajthanee Hospital PCL (BKK:RJH)

Rajthanee Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	2,813	2,741	2,739	2,348	3,365	3,118
Other Revenue	28.65	28.9	26.09	27.54	26.15	24.28
Revenue	2,842	2,770	2,765	2,375	3,392	3,142
Revenue Growth (YoY)	1.91%	0.20%	16.39%	-29.96%	7.94%	67.35%
Cost of Revenue	2,114	2,073	1,897	1,618	1,848	1,684
Gross Profit	727.59	697.56	867.42	757.68	1,544	1,458
Selling, General & Admin	345.72	317.26	345.18	222.43	244.95	183.46
Operating Expenses	345.72	317.26	345.18	222.43	244.95	183.46
Operating Income	381.87	380.3	522.25	535.25	1,299	1,274
Interest Expense	-54.62	-57.7	-52.67	-33.54	-24.48	-5.92
Interest & Investment Income	2.95	2.95	10.89	17.24	15.04	2.81
EBT Excluding Unusual Items	330.2	325.55	480.47	518.94	1,289	1,271
Pretax Income	330.2	325.55	480.47	518.94	1,289	1,271
Income Tax Expense	11.19	39.18	-1.95	103.24	255.8	254.92
Earnings From Continuing Operations	319.01	286.37	482.42	415.7	1,034	1,016
Minority Interest in Earnings	3.11	8.77	10.62	3.97	-4.45	-4.36
Net Income	322.12	295.14	493.04	419.67	1,029	1,012
Net Income to Common	322.12	295.14	493.04	419.67	1,029	1,012
Net Income Growth	-26.84%	-40.14%	17.48%	-59.22%	1.71%	145.33%
Shares Outstanding (Basic)	293	293	299	299	299	300
Shares Outstanding (Diluted)	293	293	299	299	299	300
Shares Change (YoY)	-1.43%	-2.02%	-	0.06%	-0.25%	-0.02%
EPS (Basic)	1.10	1.01	1.65	1.40	3.44	3.37
EPS (Diluted)	1.10	1.01	1.65	1.40	3.44	3.37
EPS Growth	-25.77%	-38.91%	17.48%	-59.25%	1.96%	145.38%
Free Cash Flow	283.67	409.43	-77.99	190.74	571.54	527.23
Free Cash Flow Per Share	0.97	1.40	-0.26	0.64	1.91	1.76
Dividend Per Share	0.600	0.600	0.700	1.200	2.500	2.700
Dividend Growth	-14.29%	-14.29%	-41.67%	-52.00%	-7.41%	170.00%
Gross Margin	25.61%	25.18%	31.37%	31.90%	45.52%	46.40%
Operating Margin	13.44%	13.73%	18.89%	22.53%	38.30%	40.56%
Profit Margin	11.34%	10.65%	17.83%	17.67%	30.35%	32.21%
Free Cash Flow Margin	9.98%	14.78%	-2.82%	8.03%	16.85%	16.78%
EBITDA	560.76	563.43	678.2	680.72	1,463	1,434
EBITDA Margin	19.73%	20.34%	24.53%	28.66%	43.12%	45.63%
D&A For EBITDA	178.89	183.13	155.96	145.47	163.59	159.33
EBIT	381.87	380.3	522.25	535.25	1,299	1,274
EBIT Margin	13.44%	13.73%	18.89%	22.53%	38.30%	40.56%
Effective Tax Rate	3.39%	12.04%	-	19.89%	19.84%	20.05%
Revenue as Reported	2,845	2,773	2,776	2,393	3,407	3,145

Source: S&P Global Market Intelligence. Standard template. Financial Sources.